Fosmidomycin

Fosmidomycin is a phosphonic acid-containing antibiotic that is primarily used in the treatment of malaria. It was first isolated from the bacterium Streptomyces lavendulae in 1973. Fosmidomycin works by inhibiting the enzyme 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR), which is essential for the synthesis of isoprenoids in the apicoplast of the malaria parasite Plasmodium falciparum.
Mechanism of Action[edit]
Fosmidomycin inhibits the enzyme DXR, which is involved in the non-mevalonate pathway of isoprenoid biosynthesis. Isoprenoids are vital components of several cellular processes, including cell membrane maintenance, protein modification, and synthesis of quinones and cytochromes. By inhibiting DXR, fosmidomycin disrupts these processes, leading to the death of the malaria parasite.
Clinical Use[edit]
Fosmidomycin is used in the treatment of malaria, particularly infections caused by P. falciparum. It is often used in combination with other antimalarial drugs, such as piperaquine, to increase its efficacy and prevent the development of drug resistance.
Side Effects[edit]
Common side effects of fosmidomycin include nausea, vomiting, and diarrhea. Less common side effects can include anemia, leukopenia, and thrombocytopenia. As with all antibiotics, prolonged use of fosmidomycin can lead to the development of drug-resistant strains of the malaria parasite.
Research[edit]
Research is ongoing into the potential use of fosmidomycin in the treatment of other diseases, including tuberculosis and certain types of cancer. Its ability to inhibit isoprenoid biosynthesis may make it effective against other organisms that rely on this pathway for survival.
See Also[edit]
| Antimalarial agents | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This antimalarial agents related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
